HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

One-year clinical outcome of interventionalist- versus patient-transfer strategies for primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results from the REVERSE-STEMI study.

AbstractBACKGROUND:
Traditional reperfusion options for patients with acute ST-segment elevation myocardial infarction (STEMI) presenting to non-primary percutaneous coronary intervention (PPCI)-capable hospitals generally include onsite fibrinolytics or emergency transfer for PPCI. A third option, involving interventionalist transfer, was examined in the REVERSE-STEMI study.
METHODS AND RESULTS:
A total of 334 patients with acute STEMI who presented to 5 referral hospitals with angiographic facilities but without interventionalists qualified for PPCI were randomized to receive PPCI with either an interventionalist- (n=165) or a patient-transfer (n=169) strategy. The primary end point of door-to-balloon (D2B) time and secondary end points of left ventricular ejection fraction and major adverse cardiac events (MACE) at 1-year clinical follow-up were compared between the 2 groups. Compared with the patient-transfer strategy, the interventionalist-transfer strategy resulted in a significantly shortened D2B time (median, 92 minutes versus 141 minutes; P<0.0001), with more patients having first balloon angioplasty within 90 minutes (21.2% versus 7.7%, P<0.001). This treatment strategy also was associated with higher left ventricular ejection fraction (0.60±0.07 versus 0.57±0.09, P<0.001) and improved 1-year MACE-free survival (84.8% versus 74.6%, P=0.019). Multivariate Cox proportional hazards modeling revealed that the interventionalist-transfer strategy was an independent factor for reduced risk of composite MACE (hazard ratio, 0.63; 95% CI, 0.45 to 0.88; P=0.003).
CONCLUSIONS:
The interventionalist-transfer strategy for PPCI may be effective in improving the care of patients with STEMI presenting to a non-PPCI-capable hospital, particularly in a congested cosmopolitan region where patient transfers could be prolonged.
AuthorsQi Zhang, Rui Yan Zhang, Jian Ping Qiu, Jun Feng Zhang, Xiao Long Wang, Li Jiang, Min Lei Liao, Jian Sheng Zhang, Jian Hu, Zheng Kun Yang, Wei Feng Shen
JournalCirculation. Cardiovascular quality and outcomes (Circ Cardiovasc Qual Outcomes) Vol. 4 Issue 3 Pg. 355-62 (May 2011) ISSN: 1941-7705 [Electronic] United States
PMID21521833 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Topics
  • Aged
  • Angioplasty, Balloon, Coronary
  • China
  • Electrocardiography
  • Female
  • Follow-Up Studies
  • Hospital-Physician Relations
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Myocardial Infarction (mortality, physiopathology, therapy)
  • Outcome Assessment, Health Care
  • Patient Transfer
  • Professional Practice
  • Proportional Hazards Models
  • Prospective Studies
  • Retrospective Studies
  • Stroke Volume (physiology)
  • Survival Rate
  • Technology Transfer
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: